fda pulls tirzepatide The says the Zepbound shortage is over. That's rattling the weight loss industry 🚨 FDA Moves to Permanently

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults

126 For genes in the hypoxia response pathway, Ges group revealed that the EPAS1 rs2305389 was strongly related to HAPE risk among Han Chinese

There is a complicating factor that makes tirzepatide particularly interesting from a research standpoint: some case reports and small studies have described improved hair growth in patients using tirzepatide for type 2 diabetes with concurrent androgenetic alopecia

Challenges : Consumer confusion between pharmaceutical GLP-1s and natural supplements

The market is forecast to reach USD 1,472.5 million by 2035

People are looking past conventional diets and generic advice, recognizing that a hormonal, medical approach can be the key to breaking through stubborn weight barriers